Cefradine: Difference between revisions
m Protected "Cefradine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 21: | Line 21: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 41: | Line 41: | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
[[pt:Cefradina]] | [[pt:Cefradina]] |
Revision as of 23:36, 8 August 2012
Clinical data | |
---|---|
Routes of administration | Oral, IM, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Well absorbed |
Protein binding | <10% |
Metabolism | Nil |
Elimination half-life | 0.9 hours |
Excretion | Renal, unchanged |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H19N3O4S |
Molar mass | 349.406 g/mol |
WikiDoc Resources for Cefradine |
Articles |
---|
Most recent articles on Cefradine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefradine at Clinical Trials.gov Clinical Trials on Cefradine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefradine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefradine Discussion groups on Cefradine Directions to Hospitals Treating Cefradine Risk calculators and risk factors for Cefradine
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefradine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Cefradine (INN) or cephradine (former BAN) is a first generation cephalosporin antibiotic.
Indications
It has similar spectrum of activity to cefalexin.
Dosage
Dosage by mouth for adults is 250–500 mg every 6 hours, or 500 mg to 1 g every 12 hours. In severe infections up to 1 g every 6 hours may be used. Dosages for children are based upon their weight with 25–50 mg/kg total daily dose given in 2–4 divided doses.
Formulations
Caspules containing 250 mg or 500 mg, Syrup containing 250 mg/5 ml, or vials for injection containing 500 mg or 1 g.
References
- British National Formulary 45 March 2003
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics